Archegos raises questions about Hong Kong listing rules

Deference to US disclosures stopped Baidu’s Hong Kong listing shining a spotlight on Archegos

HKEX
HKEX overhauled its secondary listing rules in 2018
Photo: HKEX

The collapse of Archegos Capital Management in the US has raised important questions about the extent to which Hong Kong should defer to foreign regulators when it comes to secondary share listings.

On March 23, one of the Chinese technology stocks Archegos was heavily invested in – Baidu – listed on the Hong Kong Stock Exchange (HKEX). But since this was a secondary listing, the Securities and Futures Regulator (SFC) chose to apply US rules on major shareholder disclosures, which are far less

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: